Evidence Hub

Dopamine D2 receptor gene Taq 1A polymorphism: genetic architecture in Indian population and comparison to global populations

Chaudhary A, Kumar P, Sharma B, Rai V

Frontiers in genetics, 2025

Abstract

OBJECTIVE: The Dopamine receptor D2 (DRD2) gene has been investigated as a candidate gene in several psychiatric and neurological disorders involving dopaminergic systems. Multiple polymorphisms have been reported in the DRD2 gene, where the DRD2 Taq1A is most widely studied and is reported to contribute to the development of several diseases/disorders. The objective was to study the DRD2 Taq1A polymorphism in the Indian population and compare it with the reported global frequency.

METHODS: The DRD2 Taq1A polymorphism was genotyped using PCR-RFLP from 400 unrelated human blood samples. In addition, a literature search on the DRD2 Taq1A polymorphism has also been conducted from 1990 to 2025. All the data obtained was grouped according to the continent as a unit to get the distribution information of the DRD2 Taq1A genotypes and alleles in healthy populations of all six continents. This was accomplished for the comparison of frequency obtained in this study with the overall geographical distribution of the DRD2 Taq1A allele reported from other parts of the world.

RESULTS: In the total 400 samples analyzed, the TT genotype and T allele frequencies were 15% and 43%, respectively. Data from 136 studies from different continents were extracted and compared with the present study. The highest T allele frequency was observed in the Asia (0.35), followed by South America (0.33) and the lowest frequencies occur in Europe and Australia (0.19). Pattern of frequencies represented by the…

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free